Skip to content

The effect of pharmacotherapy and psychosocial therapy on cognitive function and life style

The effect of pharmacotherapy and psychosocial therapy on cognitive function and life style - The effect of pharmacotherapy and psychosocial therapy on cognitive function and life style

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019297
Enrollment
200
Registered
2015-10-09
Start date
2010-04-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, mood disorder, dementia (mild), eating disorder, sleep disorder, autism spectrum disorder, breathing-related sleep disorder and epilepsy

Interventions

None listed

Sponsors

Nagoya University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals with schizophrenia, mood disorders, mild dementia, eating disorders, sleep disorders, neurodevelopmental disorders, epilepsy, and mental disorders in general, who have provided informed consent to participate in the study

Exclusion criteria

Exclusion criteria: under 18 years old,A person who is unable to give consent on their own behalf

Design outcomes

Primary

MeasureTime frame
Driving performance by driving simulator

Secondary

MeasureTime frame
Sexual function screening, cognitive function (attention, memory, executive function), ocular motion, sleep sheet, compact electroencephalograph, assessment of psychiatric symptoms, assessment of driving behavior

Countries

Japan

Contacts

Public ContactSeiko Miyata

Nagoya University Graduate School of Medicine Psychiatry

miyata.seiko.v4@f.mail.nagoya-u.ac.jp+81527442282

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026